Man Group PLC Neuro Pace Inc Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Man Group PLC holds 38,470 shares of NPCE stock, worth $274,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,470
Previous 37,942
1.39%
Holding current value
$274,675
Previous $500,000
42.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NPCE
# of Institutions
57Shares Held
19.6MCall Options Held
28.3KPut Options Held
300-
Kck Ltd. Tortola, D85.62MShares$40.1 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$24.3 Million0.62% of portfolio
-
Morgan Stanley New York, NY2.47MShares$17.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$17.4 Million1.86% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$8.17 Million3.99% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $177M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...